ArticleCureus2025
A Retrospective Study of Invasive Candidiasis in a Tertiary Teaching Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Invasive candidiasis is a leading cause of fungal infections in hospitalized and critically ill patients, with high morbidity and mortality. There are numerous factors which may predispose to its development. In recent years, there has been a change in the etiological spectrum, and emerging resistance to antifungal drugs seen in some patients, further complicating management. Aims and objectives The aim of this study was to analyze the epidemiological and microbiological profile of invasive candidiasis in a tertiary teaching hospital, with a focus on species distribution, antifungal resistance patterns, clinical risk factors, and patient outcomes. Materials and methods This retrospective study included all consecutive adult inpatients with invasive candidiasis admitted to Bharati Hospital & Research Centre, Pune, India, from April 2019 to March 2022. This cohort represents all eligible cases (n=86) identified during the study period, and therefore, the sample size was determined by case availability rather than a prior statistical calculation. Data were collected to evaluate species distribution and evolving epidemiology, identify associated risk factors, analyse antifungal susceptibility patterns, and determine mortality outcomes. Results
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.